Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 124

1.

Incidental lymphopenia and mortality: a prospective cohort study.

Warny M, Helby J, Nordestgaard BG, Birgens H, Bojesen SE.

CMAJ. 2020 Jan 13;192(2):E25-E33. doi: 10.1503/cmaj.191024.

PMID:
31932337
2.

Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study.

Warny M, Helby J, Birgens HS, Bojesen SE, Nordestgaard BG.

J Thromb Haemost. 2019 Nov;17(11):1898-1911. doi: 10.1111/jth.14574. Epub 2019 Aug 20.

PMID:
31309714
3.

Investigating macrophage-mediated inflammation in migraine using ultrasmall superparamagnetic iron oxide-enhanced 3T magnetic resonance imaging.

Khan S, Amin FM, Fliedner FP, Christensen CE, Tolnai D, Younis S, Olinger ACR, Birgens H, Daldrup-Link H, Kjær A, Larsson HBW, Lindberg U, Ashina M.

Cephalalgia. 2019 Oct;39(11):1407-1420. doi: 10.1177/0333102419848122. Epub 2019 May 19.

PMID:
31104505
4.

Bone marrow mononuclear cell telomere length in acute myeloid leukaemia and high-risk myelodysplastic syndrome.

Warny M, Helby J, Sengeløv H, Nordestgaard BG, Birgens H, Bojesen SE.

Eur J Haematol. 2019 Mar;102(3):218-226. doi: 10.1111/ejh.13196. Epub 2019 Jan 22.

PMID:
30427547
5.

Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study.

Warny M, Helby J, Nordestgaard BG, Birgens H, Bojesen SE.

PLoS Med. 2018 Nov 1;15(11):e1002685. doi: 10.1371/journal.pmed.1002685. eCollection 2018 Nov.

6.

Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia.

Toft N, Birgens H, Abrahamsson J, Griškevičius L, Hallböök H, Heyman M, Klausen TW, Jónsson ÓG, Palk K, Pruunsild K, Quist-Paulsen P, Vaitkeviciene G, Vettenranta K, Åsberg A, Frandsen TL, Marquart HV, Madsen HO, Norén-Nyström U, Schmiegelow K.

Leukemia. 2018 Mar;32(3):606-615. doi: 10.1038/leu.2017.265. Epub 2017 Aug 18.

PMID:
28819280
7.

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial.

Berentsen S, Randen U, Oksman M, Birgens H, Tvedt THA, Dalgaard J, Galteland E, Haukås E, Brudevold R, Sørbø JH, Næss IA, Malecka A, Tjønnfjord GE.

Blood. 2017 Jul 27;130(4):537-541. doi: 10.1182/blood-2017-04-778175. Epub 2017 May 22.

PMID:
28533306
8.

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.

Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, Baccarani M, Deininger MW, Cervantes F, Fujihara S, Ortmann CE, Menssen HD, Kantarjian H, O'Brien SG, Druker BJ; IRIS Investigators.

N Engl J Med. 2017 Mar 9;376(10):917-927. doi: 10.1056/NEJMoa1609324.

9.

Multimodal intervention integrated into the clinical management of acute leukemia improves physical function and quality of life during consolidation chemotherapy: a randomized trial 'PACE-AL'.

Jarden M, Møller T, Christensen KB, Kjeldsen L, Birgens HS, Adamsen L.

Haematologica. 2016 Jul;101(7):e316-9. doi: 10.3324/haematol.2015.140152. Epub 2016 Apr 1. No abstract available.

10.

[Severe haemolysis caused by Mycoplasma pneumoniae].

Bohr AL, Aagaard TG, Birgens H, Søborg C.

Ugeskr Laeger. 2015 Oct 9;177(43):V03150207. Danish.

PMID:
26509456
11.

Severe G6PD Deficiency Due to a New Missense Mutation in an Infant of Northern European Descent.

Warny M, Lausen B, Birgens H, Knabe N, Petersen J.

J Pediatr Hematol Oncol. 2015 Nov;37(8):e497-9. doi: 10.1097/MPH.0000000000000435.

PMID:
26479991
12.

Novel 31.2 kb α0 Deletion in a Palestinian Family with α-Thalassemia.

Brieghel C, Birgens H, Frederiksen H, Hertz JM, Steenhof M, Petersen J.

Hemoglobin. 2015;39(5):346-9. doi: 10.3109/03630269.2015.1054512. Epub 2015 Jun 26.

PMID:
26114741
13.

Haemostatic function and biomarkers of endothelial damage before and after platelet transfusion in patients with acute myeloid leukaemia.

Larsen AM, Leinøe EB, Johansson PI, Larsen R, Wantzin P, Birgens H, Ostrowski SR.

Transfus Med. 2015 Jun;25(3):174-83. doi: 10.1111/tme.12209. Epub 2015 Jun 5.

PMID:
26043955
14.

Prevalence of glucose-6-phosphate dehydrogenase deficiency and diagnostic challenges in 1500 immigrants in Denmark examined for haemoglobinopathies.

Warny M, Klausen TW, Petersen J, Birgens H.

Scand J Clin Lab Invest. 2015 Sep;75(5):390-7. doi: 10.3109/00365513.2015.1031692. Epub 2015 Apr 30.

PMID:
25925739
15.

Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.

Toft N, Birgens H, Abrahamsson J, Griškevičius L, Hallböök H, Heyman M, Klausen TW, Jónsson ÓG, Palk K, Pruunsild K, Quist-Paulsen P, Vaitkeviciene G, Vettenranta K, Asberg A, Helt LR, Frandsen T, Schmiegelow K.

Eur J Haematol. 2016 Feb;96(2):160-9. doi: 10.1111/ejh.12562. Epub 2015 Apr 24.

PMID:
25867866
16.

Haemostatic function and biomarkers of endothelial damage before and after RBC transfusion in patients with haematologic disease.

Larsen AM, Leinøe EB, Johansson PI, Birgens H, Ostrowski SR.

Vox Sang. 2015 Jul;109(1):52-61. doi: 10.1111/vox.12249. Epub 2015 Mar 6.

PMID:
25754541
17.

JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate.

Nielsen C, Bojesen SE, Nordestgaard BG, Kofoed KF, Birgens HS.

Haematologica. 2014 Sep;99(9):1448-55. doi: 10.3324/haematol.2014.107631. Epub 2014 Jun 6.

18.

Need for reclassification of diabetes secondary to iron overload in the ADA and WHO classifications.

Ellervik C, Birgens H, Mandrup-Poulsen T.

Diabetes Care. 2014 Jun;37(6):e137-8. doi: 10.2337/dc14-0119. No abstract available.

PMID:
24855170
19.

Hereditary xerocytosis and familial haemolysis due to mutation in the PIEZO1 gene: a simple diagnostic approach.

Sandberg MB, Nybo M, Birgens H, Frederiksen H.

Int J Lab Hematol. 2014 Aug;36(4):e62-5. doi: 10.1111/ijlh.12172. Epub 2013 Dec 6. No abstract available.

PMID:
24314002
20.

Complying with the European Clinical Trials directive while surviving the administrative pressure - an alternative approach to toxicity registration in a cancer trial.

Frandsen TL, Heyman M, Abrahamsson J, Vettenranta K, Åsberg A, Vaitkeviciene G, Pruunsild K, Toft N, Birgens H, Hallböök H, Quist-Paulsen P, Griškevičius L, Helt L, Hansen BV, Schmiegelow K.

Eur J Cancer. 2014 Jan;50(2):251-9. doi: 10.1016/j.ejca.2013.09.027. Epub 2013 Nov 11.

PMID:
24231337

Supplemental Content

Loading ...
Support Center